Rich Capital Holdings Limited (SGX:5G4)
0.0010
0.00 (0.00%)
At close: Jul 23, 2025
Blueprint Medicines Balance Sheet
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 2.41 | 3.65 | 3.93 | 1.44 | 2.6 | Upgrade |
Short-Term Investments | 0.05 | 0.05 | 0.07 | 0.03 | 0.16 | Upgrade |
Cash & Short-Term Investments | 2.45 | 3.7 | 3.99 | 1.47 | 2.77 | Upgrade |
Cash Growth | -33.77% | -7.29% | 170.83% | -46.75% | -50.88% | Upgrade |
Accounts Receivable | 2.06 | 2.83 | 5.59 | 0.89 | - | Upgrade |
Other Receivables | 0.01 | 0.02 | 0.01 | 0.03 | 0.05 | Upgrade |
Receivables | 2.07 | 2.85 | 5.6 | 0.92 | 0.05 | Upgrade |
Prepaid Expenses | 0.04 | 0.05 | 0.03 | 0.02 | 0.03 | Upgrade |
Other Current Assets | - | - | - | 11.32 | 11.31 | Upgrade |
Total Current Assets | 4.56 | 6.6 | 9.62 | 13.74 | 14.15 | Upgrade |
Property, Plant & Equipment | 0.13 | 0.21 | 0.1 | 0.03 | 0.1 | Upgrade |
Total Assets | 4.69 | 6.81 | 9.72 | 13.77 | 14.25 | Upgrade |
Accounts Payable | 0.8 | 1.54 | 0.6 | 0.13 | - | Upgrade |
Accrued Expenses | 0.72 | 0.93 | 3.72 | 0.97 | 0.31 | Upgrade |
Short-Term Debt | - | - | - | - | 8.64 | Upgrade |
Current Portion of Leases | 0.05 | 0.05 | 0.06 | 0.03 | 0.06 | Upgrade |
Current Unearned Revenue | - | - | - | 0.73 | 0.02 | Upgrade |
Other Current Liabilities | 0.12 | 0.16 | 0.17 | 8.88 | 0.24 | Upgrade |
Total Current Liabilities | 1.69 | 2.68 | 4.56 | 10.73 | 9.28 | Upgrade |
Long-Term Leases | 0.04 | 0.09 | 0.03 | - | 0.03 | Upgrade |
Total Liabilities | 1.72 | 2.77 | 4.59 | 10.73 | 9.31 | Upgrade |
Common Stock | 72.57 | 72.57 | 72.57 | 72.57 | 72.57 | Upgrade |
Retained Earnings | -70.92 | -69.82 | -68.68 | -70.75 | -69.04 | Upgrade |
Comprehensive Income & Other | 0.21 | 0.21 | 0.16 | 0.14 | 0.33 | Upgrade |
Total Common Equity | 1.86 | 2.96 | 4.04 | 1.96 | 3.86 | Upgrade |
Minority Interest | 1.11 | 1.08 | 1.08 | 1.08 | 1.09 | Upgrade |
Shareholders' Equity | 2.97 | 4.04 | 5.12 | 3.04 | 4.94 | Upgrade |
Total Liabilities & Equity | 4.69 | 6.81 | 9.72 | 13.77 | 14.25 | Upgrade |
Total Debt | 0.09 | 0.14 | 0.1 | 0.03 | 8.73 | Upgrade |
Net Cash (Debt) | 2.36 | 3.56 | 3.9 | 1.44 | -5.96 | Upgrade |
Net Cash Growth | -33.70% | -8.50% | 169.74% | - | - | Upgrade |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade |
Filing Date Shares Outstanding | 7,343 | 7,343 | 7,343 | 7,343 | 7,343 | Upgrade |
Total Common Shares Outstanding | 7,343 | 7,343 | 7,343 | 7,343 | 7,343 | Upgrade |
Working Capital | 2.88 | 3.92 | 5.05 | 3.01 | 4.88 | Upgrade |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
Tangible Book Value | 1.86 | 2.96 | 4.04 | 1.96 | 3.86 | Upgrade |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
Machinery | 0.09 | 0.09 | 0.03 | 0.03 | 0.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.